Horvath Susan 4
4 · Sun BioPharma, Inc. · Filed Jan 3, 2019
Insider Transaction Report
Form 4
Horvath Susan
V.P. of Finance & CFO
Transactions
- Purchase
Convertible Promissory Note
2018-12-31+23,625→ 0 totalExercise: $3.50From: 2018-12-31Exp: 2019-06-30→ Common Stock (6,750 underlying) - Purchase
Warrant (right to buy)
2018-12-31+13,500→ 13,500 totalExercise: $4.50From: 2018-12-31Exp: 2023-12-31→ Common Stock (13,500 underlying)
Footnotes (2)
- [F1]All amounts due under the note will automatically convert into shares of common stock of the Issuer based on an initial conversion price of $3.50 per share upon maturity (subject to certain adjustments).
- [F2]The reporting person purchased the convertible promissory note and warrants, in a single transaction, for an aggregate amount of $23,625.